Diabetes Reversal Group (DRG)
Healthcare Advisory Board Member – Innovation in Chronic Disease
Diabetes Reversal Group seeks senior healthcare leaders to join its Strategic Advisory Board, providing guidance on chronic disease management, physician licensing, employer partnerships, and virtual care expansion.
Diabetes Reversal Group (DRG) operates a patented, clinically validated Type 2 diabetes reversal programme delivered through structured virtual care. With 17 years of operating history and a documented track record of participants reducing or eliminating diabetes medications, DRG is now scaling through physician licensing, employer health partnerships, consumer programmes, and international expansion.
Advisory Board Members contribute approximately one to two hours per month through virtual meetings and strategic discussions. The role focuses on guiding commercialisation strategy, market expansion, and partnership development as DRG extends its reach across providers, payers, and employer health channels.
- Provide strategic guidance on market expansion, commercialisation, and company growth priorities.
- Advise leadership on physician licensing models, employer health partnerships, and virtual care platform development.
- Share expertise on chronic disease management, healthcare innovation, reimbursement structures, and value-based care.
- Introduce relevant strategic partners, payers, physician organisations, employers, or investors when appropriate.
- Participate in periodic virtual Advisory Board meetings and strategic planning discussions.
- Senior leadership experience in healthcare, digital health, healthcare technology, employer health, or related fields.
- Track record of building, scaling, advising, or investing in healthcare organisations.
- Strong professional networks across providers, payers, physician organisations, employers, or healthcare investors.
- Genuine interest in advancing innovative approaches to chronic disease management.
- Availability to contribute approximately one to two hours per month.
Diabetes Reversal Group (DRG) delivers the world's only patented, clinically proven Type 2 diabetes reversal system through a structured virtual care programme. Operating for 17 years and having generated over $38 million in revenue, DRG is expanding through physician licensing, employer partnerships, consumer programmes, and international markets.
Trusted by fast-growing companies around the world





